Sanford-Burnham Medical Research Institute: Making Sure New Drugs Aren't Lost In Translation

With a metabolic-disease deal with Takeda Pharmaceuticals already under its belt, Sanford Burnham aims to extend its academic prowess to more business-oriented opportunities. Chief Business Officer Paul Laikind, PhD, aims to inject entrepreneural blood into Sanford-Burnham's scientific muscle.